01—Abstract
Summary
Summary of the 10-K filed February 24, 2005. Cited figures are marked; the original filing is the authoritative source.
3M's 2004 Form 10-K shows a record year: net sales rose 9.8% to $20.011 billiona, operating income grew 23.3% to $4.578 billion (22.9% margin, up from 20.4%), and net income reached $2.990 billion, or $3.75 per diluted share, versus $3.02 in 2003.
Management attributes the gains to core volume growth of 6.2%, roughly $400 millionb of annual benefit from corporate initiatives (Six Sigma, Global Sourcing Effectiveness, 3M Acceleration, eProductivity), and a weaker U.S. dollar that boosted operating income by an estimated $286 million. Display and Graphics (optical films for flat-panel displays) was the standout segment, with 10.4% local-currency sales growth and a 27.8% increase in operating income. Growth was broad-based, with all seven segments contributing to sales growth.
Balance sheet and cash flow strengthened considerably. Operating cash flow was $4.282 billion, and net debt fell to $64 millionc from $1.101 billion a year earlier, with cash of $2.757 billion. Total debt was $2.821 billion, about 21% of total capital.
The company returned roughly $2.9 billiond to shareholders through buybacks and dividends, and the Board authorized up to $2.0 billion in repurchases for January 2005 through January 2006. The dividend was raised to $0.42 per quarter, the 47th consecutive annual increase. The main investor risk is legal exposure.
The respirator mask/asbestos reserve was increased by $40 million to $248 million, against $464 million of insurance receivables. Breast implant insurance receivables of $278 million depend on insurer payments that remain uncertain.
The company faces a proposed settlement of indirect-purchaser tape antitrust claims, which management says is not material, plus PFOA/PFOS environmental reviews and a pending West Virginia silicosis suit. Management states that these matters would not have a material adverse effect on consolidated financial position, but future charges could affect results in a given period.
02—Key points
Key Highlights
- Record 2004 results: net sales of $20.0 billion (+9.8%), operating income of $4.58 billion (+23.3%), and diluted EPS of $3.75 (+24%).
- Operating margin expanded to 22.9% from 20.4%, driven by volume growth, productivity, corporate cost initiatives (over $400 million benefit), and currency tailwinds (about $286 million).
- Display and Graphics was the top performer: sales +15%, operating income +27.8% to $1.13 billion, led by optical films for flat-panel displays.
- Balance sheet strengthened: net debt fell to $64 million from $1.1 billion, cash rose to $2.76 billion, and operating cash flow reached $4.28 billion.
- Shareholder returns were significant: about $2.9 billion in buybacks and dividends in 2004, a new $2.0 billion repurchase authorization, and a 47th consecutive annual dividend increase to $0.42 per quarter.
- Legal reserves rose: respirator mask/asbestos liabilities increased $40 million to $248 million, offset by $464 million of insurance receivables, and the Mississippi $22.5 million verdict was reversed.
- Telecom goodwill (about $300 million) and pension expense (up to $325 million from $168 million) are watch items for 2005.
03—Questions
Frequently Asked Questions
How did 3M's profitability change in 2004?
Operating income rose 23.3% to $4.578 billion, and operating margin improved to 22.9% from 20.4% in 2003. Net income rose to $2.990 billion, or $3.75 per diluted share. Drivers included higher volumes, productivity and cost programs worth over $400 million, favorable currency effects, and the absence of the 2003 $93 million LePage's charge. Higher pension expense of about $157 million partly offset these gains.
Is 3M's debt level a concern for investors?
No, not based on this filing. Total debt fell to $2.821 billion from $2.937 billion, and net debt dropped to $64 million. The debt-to-total-capital ratio was about 21%, down from 27%. The company holds AA (S&P) and Aa1 (Moody's) ratings and has ample commercial paper and credit facilities. The 2005 maturities of about $1.4 billion include $556 million of convertible notes and $350 million of dealer remarketable securities, which management does not expect to be redeemed in 2005.
What are the biggest legal and financial risks in the filing?
The main exposures are respirator mask/asbestos claims (about 76,600 claimants, with reserves of $248 million and receivables of $464 million), breast implant insurance recoveries ($278 million, with about $215 million still owed by insurers), and antitrust suits over transparent tape, which management says are not material. Environmental matters include PFOA/PFOS regulatory reviews and a Decatur, Alabama class action. Management says none is expected to have a material adverse effect on financial position, but adverse rulings or congressional asbestos legislation could trigger material charges.
What does 3M expect for 2005?
Management expects continued broad-based sales growth, further optical film growth, and about $400 million of additional operating income from cost programs. Capital spending is planned at about $950 million, and pension expense is expected to rise to about $342 million. The company plans a 2005 change to the 364-day credit facility and the expected return on U.S. pension assets will drop to 8.75%. Currency remains a risk, since about 60% of revenue is generated outside the U.S. and roughly half of that exposure is hedged.
How is 3M returning capital to shareholders?
In 2004, 3M repurchased about $1.79 billion of stock and paid $1.125 billion in dividends, $1.44 per share. The Board authorized repurchases of up to $2.0 billion from January 2005 through January 2006, and in February 2005 raised the quarterly dividend to $0.42 per share, an annualized $1.68. This is the 47th consecutive annual increase, and dividends have been paid since 1916.
04—Continue